Free eCTD viewers open a sequence. Enterprise review platforms answer the questions reviewers actually ask. Here’s what separates them — including the FDA-forms problem nobody mentions in demos.
Health authority questions are predictable — they cluster by discipline and CTD module. Teams that prepare for likely questions before submission cut review cycles and save hundreds of hours.
Agency correspondence is legally consequential, deadline-driven, and — at most companies — scattered across inboxes. Here’s what a real correspondence system of record looks like.
Most regulatory intelligence software is a firehose. The useful question is not ‘what changed?’ but ‘what changed that affects MY applications?’ — and that requires portfolio-aware scoring.
What submission planning software actually needs to do in 2026 — and how to evaluate the options, from Veeva RIM to generic project tools to purpose-built planners.
A practical buyer’s guide: 12 questions pharma and biotech companies should ask when evaluating AI-powered regulatory technology platforms.
An inside look at DnXT’s Compliance Monitoring Dashboard — 6 compliance agents, 8 daily checks, and how continuous monitoring catches problems before auditors do.
Why life sciences may need regulatory platforms designed for AI from the ground up — and the honest counter-arguments to that position.
A practical look at eCTD validation: 23 compliance rules, multi-region support, and how AI helps with preparation while deterministic rules handle the actual checking.
A look inside DnXT’s V5 workflow engine — 50+ endpoints, state machine architecture, and the preCheck pattern that lets AI agents look before they leap.
